WEST PHARMACEUTICAL SERVICES INC WST
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
7/9
Piotroski F — financial health
9.34
Altman Z″ — distress risk · safe
12.4%
Dividend payout · safe
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $3.1B | $493.7M | $1.1B | $468.9M | $3.2B |
| 2024 | $2.9B | $492.7M | $998.5M | $276.4M | $2.7B |
| 2023 | $2.9B | $593.4M | $1.1B | $414.5M | $2.9B |
| 2022 | $2.9B | $585.9M | $1.1B | $439.4M | $2.7B |
| 2021 | $2.8B | $661.8M | $1.2B | $330.6M | $2.3B |
| 2020 | $2.1B | $346.2M | $767.8M | $298.1M | $1.9B |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Campbell Shane Alden | SVP, Proprietary Segment | 2026-05-12 | Option exercise | 296 | — |
| Campbell Shane Alden | SVP, Proprietary Segment | 2026-05-12 | Tax withheld | 84 | $312.07 |
| Campbell Shane Alden | SVP, Proprietary Segment | 2026-05-12 | Option exercise | 474 | — |
| Campbell Shane Alden | SVP, Proprietary Segment | 2026-05-12 | Tax withheld | 135 | $312.07 |
| Pucci Paolo | director | 2026-05-04 | Grant | 791 | — |
| Michels Douglas A | director | 2026-05-04 | Grant | 791 | — |
| Lockhart Stephen H | director | 2026-05-04 | Grant | 791 | — |
| LAI GOLDMAN MYLA | director | 2026-05-04 | Grant | 791 | — |
Why these scores methodology →
Piotroski F-score: 7/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 9.34 (safe)
- Working capital / assets 0.31
- Retained earnings / assets 1.025
- EBIT / assets 0.137
- Equity / liabilities 2.903
Source: SEC EDGAR filings · CIK 0000105770 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.